Mucicarmine kit is often used to identify primary tumour sites, distinguishing mucin-negative undifferentiated squamous cell lesions from mucin-positive adenocarcinomas. It can also be used as indicative of diseases such as asthma, bronchitis, chronic obstructive pulmonary disease and cystic fibrosis.